You searched for Drugs Controller General of India

India is mulling to shut e-pharmacies over misuse of data, according to a report

Centre considers banning e-pharmacies across India; concern over data misuse

PGurus Newsdesk - March 14, 2023 1

E-pharmacies on government radar over data privacy, malpractices In a big jolt to e-pharmacies, the Centre is mulling regulations and stringent action against online drug...

A feather in the cap for DRDO, known mostly for missile-based accomplishments to venture into drugs for COVID

India’s DRDO in association with Dr. Reddy’s Laboratories produces oral drug for COVID-19 patients

Team PGurus - May 8, 2021 1

In a major development, India’s prestigious Defence Research and Development Organisation (DRDO) has developed an anti-Covid oral drug for emergency use. This oral drug...

The Acharyas of Ayurveda came together and developed a drug and treatment protocol for COVID-19 which they submitted to the Ministry of Ayush under the Government of India

Global conspiracy to derail India’s Ayurveda

Team PGurus - June 8, 2020 33

Pharma companies across the globe are struggling hard to develop a vaccine to control the COVID-19 patients “Due to the global pandemic this is certainly...

PCV14 may be administered to infants 6, 10, and 14 weeks of age in 3 doses

DCGI clears Biological E’s 14-valent pneumococcal conjugate vaccine

PGurus Newsdesk - December 17, 2022 0

Drugs regulator approves BE-PCV14 vaccine to protect infants against Streptococcus pneumoniae infection Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that...

India`s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, and in the 12-17 age group with certain conditions on March 9

DGCI panel approve Serum Institute’s Covovax EUA for 7-11 age group

PGurus Newsdesk - June 25, 2022 0

DGCI will review the recommendation before nodding for final approval Drugs Controller General of India (DCGI) on Friday recommended Emergency Use Authorization (EUA) for Serum...

CCPA found faults with the company’s claims of being the “World’s No.1 sensitivity toothpaste

Sensodyne fined Rs.10 lakh by consumer body over “misleading ads”, orders company to drop...

PGurus Newsdesk - March 23, 2022 1

Sensodyne ordered to stop misleading ads b CCPA The Central Consumer Protection Authority (CCPA) has imposed a fine of Rs.10 lakh on Sensodyne. Further, it...

People above 18 years of age, with a vaccination history of more than five months but less than seven months are eligible to participate in the phase 3 trial

AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Friday

PGurus Newsdesk - March 10, 2022 0

AIIMS Delhi to start clinical trials of Bharat Biotech’s intranasal booster vaccine All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials...

As against injectable vaccines, intranasal vaccine is claimed to be easy to administer during mass inoculation campaigns

Bharat Biotech gets a nod from DGCI for phase 3 trials of intranasal COVID-19...

PGurus Newsdesk - January 5, 2022 0

Bharat Biotech gets SEC approval for phase 3 clinical trials of nasal vaccine as a booster shot As India stares at the third wave of...

Increasing the Covaxin shelf life helps reduce the carbon footprint, says the company

Shelf life of Covaxin extended to 12 months from the date of manufacture

Team PGurus - December 20, 2021 1

Extended shelf-life for Covaxin helps lessen vaccine wastage The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's...

Was banning vaccine exports at the height of the Second Wave in India, a bad move? SII Chairman thinks so

Vaccine export ban ‘very bad’ move; son warned not to speak against it: SII’s...

Team PGurus - August 14, 2021 1

Cyrus Poonawalla: Vaccine export ban very bad move by Centre Cyrus Poonawalla, chairman of the Serum Institute of India (SII), on Friday, termed the ban...